We report on a Kenyan woman who developed bullous erythema multiforme, in association with Malarone treatment.
Get full access to this article
View all access options for this article.
References
1.
PatelSN, KainKC. Atovaquone/proguanil for the prophylaxis and treatment of malaria. Expert Rev Anti Infect Ther2005;3:849–61
2.
RidleyRG, HudsonAT. Chemotherapy of malaria. Curr Opin Infect Dis1998;11:691–705
3.
OverboschD. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries. J Travel Med2003;10:S16–20
